A new magnetic resonance imaging (MRI) contrast agent being tested by researchers at Case Western Reserve University not only pinpoints breast cancers at early stages but differentiates between aggressive and slow-growing ...
Sep 25, 2017
0
132
Surgeons were able to identify and remove a greater number of cancerous nodules from lung cancer patients when combining intraoperative molecular imaging (IMI) - through the use of a contrast agent that makes tumor cells ...
Jul 27, 2017
0
6
Scientists from the National University of Singapore (NUS) have developed a novel nanodiamond-based contrast agent—a chemical "dye" used to enhance the visibility of internal body structures in magnetic resonance imaging ...
May 2, 2017
0
0
In the war on cancer, powerful chemotherapy agents are increasingly packaged with immunotherapy that primes a patient's immune system to better battle the disease.
Apr 17, 2017
0
2
A team led by researchers from the Stanford University School of Medicine has demonstrated a way to diagnose cancer without resorting to surgery, raising the possibility of far fewer biopsies.
Apr 4, 2017
0
58
(HealthDay)—Patients with psoriasis may have a higher risk of melanoma and hematologic cancers than the general population, according to a study published in the April issue of the Journal of the American Academy of Dermatology.
Mar 28, 2017
0
25
A veteran with a rare type of cancer may have developed the condition after being exposed to Agent Orange during the Vietnam War, reveal doctors writing in the journal BMJ Case Reports.
Dec 1, 2016
0
1
Among women with metastatic breast cancer, treatment with a drug that is biosimilar to the breast cancer drug trastuzumab resulted in an equivalent overall response rate at 24 weeks compared with trastuzumab, according to ...
Dec 1, 2016
0
4
A team of Russian scientists led by MIPT's Prof. Alexander Kiselyov has synthesized an antitumor compound that could be used to fight chemoresistant cancer. The research findings were published in the European Journal of ...
Dec 1, 2016
0
1
Among women with high-risk early breast cancer, the use of tailored dose-dense chemotherapy compared with standard adjuvant chemotherapy did not result in a statistically significant improvement in breast cancer recurrence-free ...
Nov 8, 2016
0
0
